The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global S1P Receptor Modulator Drugs Market Research Report 2025

Global S1P Receptor Modulator Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1714950

No of Pages : 84

Ask Your Query

Synopsis

Market Analysis and Insights: Global S1P Receptor Modulator Drugs Market
The global S1P Receptor Modulator Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Fingolimod accounting for % of the S1P Receptor Modulator Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

China S1P Receptor Modulator Drugs market size is valued at US$ million in 2021, while the North America and Europe S1P Receptor Modulator Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe S1P Receptor Modulator Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global S1P Receptor Modulator Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global S1P Receptor Modulator Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global S1P Receptor Modulator Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global S1P Receptor Modulator Drugs market.

Global S1P Receptor Modulator Drugs Scope and Market Size
S1P Receptor Modulator Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global S1P Receptor Modulator Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Fingolimod
  • Ozanimod
  • Siponimod
  • Others

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Novartis International AG
  • Bristol Myers Squibb
  • Pfizer Inc.
  • Sanofi SA
  • Merck & Co., Inc.
  • Biogen Inc.
  • Roche Holding AG
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global S1P Receptor Modulator Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Fingolimod
1.2.3 Ozanimod
1.2.4 Siponimod
1.2.5 Others
1.3 Market by Application
1.3.1 Global S1P Receptor Modulator Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global S1P Receptor Modulator Drugs Market Perspective (2017-2028)
2.2 S1P Receptor Modulator Drugs Growth Trends by Region
2.2.1 S1P Receptor Modulator Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 S1P Receptor Modulator Drugs Historic Market Size by Region (2017-2022)
2.2.3 S1P Receptor Modulator Drugs Forecasted Market Size by Region (2023-2028)
2.3 S1P Receptor Modulator Drugs Market Dynamics
2.3.1 S1P Receptor Modulator Drugs Industry Trends
2.3.2 S1P Receptor Modulator Drugs Market Drivers
2.3.3 S1P Receptor Modulator Drugs Market Challenges
2.3.4 S1P Receptor Modulator Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top S1P Receptor Modulator Drugs Players by Revenue
3.1.1 Global Top S1P Receptor Modulator Drugs Players by Revenue (2017-2022)
3.1.2 Global S1P Receptor Modulator Drugs Revenue Market Share by Players (2017-2022)
3.2 Global S1P Receptor Modulator Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by S1P Receptor Modulator Drugs Revenue
3.4 Global S1P Receptor Modulator Drugs Market Concentration Ratio
3.4.1 Global S1P Receptor Modulator Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by S1P Receptor Modulator Drugs Revenue in 2021
3.5 S1P Receptor Modulator Drugs Key Players Head office and Area Served
3.6 Key Players S1P Receptor Modulator Drugs Product Solution and Service
3.7 Date of Enter into S1P Receptor Modulator Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 S1P Receptor Modulator Drugs Breakdown Data by Type
4.1 Global S1P Receptor Modulator Drugs Historic Market Size by Type (2017-2022)
4.2 Global S1P Receptor Modulator Drugs Forecasted Market Size by Type (2023-2028)
5 S1P Receptor Modulator Drugs Breakdown Data by Application
5.1 Global S1P Receptor Modulator Drugs Historic Market Size by Application (2017-2022)
5.2 Global S1P Receptor Modulator Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America S1P Receptor Modulator Drugs Market Size (2017-2028)
6.2 North America S1P Receptor Modulator Drugs Market Size by Country (2017-2022)
6.3 North America S1P Receptor Modulator Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe S1P Receptor Modulator Drugs Market Size (2017-2028)
7.2 Europe S1P Receptor Modulator Drugs Market Size by Country (2017-2022)
7.3 Europe S1P Receptor Modulator Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific S1P Receptor Modulator Drugs Market Size (2017-2028)
8.2 Asia-Pacific S1P Receptor Modulator Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific S1P Receptor Modulator Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America S1P Receptor Modulator Drugs Market Size (2017-2028)
9.2 Latin America S1P Receptor Modulator Drugs Market Size by Country (2017-2022)
9.3 Latin America S1P Receptor Modulator Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa S1P Receptor Modulator Drugs Market Size (2017-2028)
10.2 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Company Detail
11.1.2 Novartis International AG Business Overview
11.1.3 Novartis International AG S1P Receptor Modulator Drugs Introduction
11.1.4 Novartis International AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022)
11.1.5 Novartis International AG Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb S1P Receptor Modulator Drugs Introduction
11.2.4 Bristol Myers Squibb Revenue in S1P Receptor Modulator Drugs Business (2017-2022)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Detail
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. S1P Receptor Modulator Drugs Introduction
11.3.4 Pfizer Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022)
11.3.5 Pfizer Inc. Recent Development
11.4 Sanofi SA
11.4.1 Sanofi SA Company Detail
11.4.2 Sanofi SA Business Overview
11.4.3 Sanofi SA S1P Receptor Modulator Drugs Introduction
11.4.4 Sanofi SA Revenue in S1P Receptor Modulator Drugs Business (2017-2022)
11.4.5 Sanofi SA Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Detail
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. S1P Receptor Modulator Drugs Introduction
11.5.4 Merck & Co., Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022)
11.5.5 Merck & Co., Inc. Recent Development
11.6 Biogen Inc.
11.6.1 Biogen Inc. Company Detail
11.6.2 Biogen Inc. Business Overview
11.6.3 Biogen Inc. S1P Receptor Modulator Drugs Introduction
11.6.4 Biogen Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022)
11.6.5 Biogen Inc. Recent Development
11.7 Roche Holding AG
11.7.1 Roche Holding AG Company Detail
11.7.2 Roche Holding AG Business Overview
11.7.3 Roche Holding AG S1P Receptor Modulator Drugs Introduction
11.7.4 Roche Holding AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022)
11.7.5 Roche Holding AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global S1P Receptor Modulator Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Fingolimod
Table 3. Key Players of Ozanimod
Table 4. Key Players of Siponimod
Table 5. Key Players of Others
Table 6. Global S1P Receptor Modulator Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global S1P Receptor Modulator Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global S1P Receptor Modulator Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global S1P Receptor Modulator Drugs Market Share by Region (2017-2022)
Table 10. Global S1P Receptor Modulator Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global S1P Receptor Modulator Drugs Market Share by Region (2023-2028)
Table 12. S1P Receptor Modulator Drugs Market Trends
Table 13. S1P Receptor Modulator Drugs Market Drivers
Table 14. S1P Receptor Modulator Drugs Market Challenges
Table 15. S1P Receptor Modulator Drugs Market Restraints
Table 16. Global S1P Receptor Modulator Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global S1P Receptor Modulator Drugs Market Share by Players (2017-2022)
Table 18. Global Top S1P Receptor Modulator Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S1P Receptor Modulator Drugs as of 2021)
Table 19. Ranking of Global Top S1P Receptor Modulator Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by S1P Receptor Modulator Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players S1P Receptor Modulator Drugs Product Solution and Service
Table 23. Date of Enter into S1P Receptor Modulator Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global S1P Receptor Modulator Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global S1P Receptor Modulator Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global S1P Receptor Modulator Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global S1P Receptor Modulator Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global S1P Receptor Modulator Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global S1P Receptor Modulator Drugs Revenue Market Share by Application (2017-2022)
Table 31. Global S1P Receptor Modulator Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global S1P Receptor Modulator Drugs Revenue Market Share by Application (2023-2028)
Table 33. North America S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Novartis International AG Company Detail
Table 44. Novartis International AG Business Overview
Table 45. Novartis International AG S1P Receptor Modulator Drugs Product
Table 46. Novartis International AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million)
Table 47. Novartis International AG Recent Development
Table 48. Bristol Myers Squibb Company Detail
Table 49. Bristol Myers Squibb Business Overview
Table 50. Bristol Myers Squibb S1P Receptor Modulator Drugs Product
Table 51. Bristol Myers Squibb Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million)
Table 52. Bristol Myers Squibb Recent Development
Table 53. Pfizer Inc. Company Detail
Table 54. Pfizer Inc. Business Overview
Table 55. Pfizer Inc. S1P Receptor Modulator Drugs Product
Table 56. Pfizer Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million)
Table 57. Pfizer Inc. Recent Development
Table 58. Sanofi SA Company Detail
Table 59. Sanofi SA Business Overview
Table 60. Sanofi SA S1P Receptor Modulator Drugs Product
Table 61. Sanofi SA Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million)
Table 62. Sanofi SA Recent Development
Table 63. Merck & Co., Inc. Company Detail
Table 64. Merck & Co., Inc. Business Overview
Table 65. Merck & Co., Inc. S1P Receptor Modulator Drugs Product
Table 66. Merck & Co., Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million)
Table 67. Merck & Co., Inc. Recent Development
Table 68. Biogen Inc. Company Detail
Table 69. Biogen Inc. Business Overview
Table 70. Biogen Inc. S1P Receptor Modulator Drugs Product
Table 71. Biogen Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million)
Table 72. Biogen Inc. Recent Development
Table 73. Roche Holding AG Company Detail
Table 74. Roche Holding AG Business Overview
Table 75. Roche Holding AG S1P Receptor Modulator Drugs Product
Table 76. Roche Holding AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million)
Table 77. Roche Holding AG Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global S1P Receptor Modulator Drugs Market Share by Type: 2021 VS 2028
Figure 2. Fingolimod Features
Figure 3. Ozanimod Features
Figure 4. Siponimod Features
Figure 5. Others Features
Figure 6. Global S1P Receptor Modulator Drugs Market Share by Application in 2021 & 2028
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. S1P Receptor Modulator Drugs Report Years Considered
Figure 12. Global S1P Receptor Modulator Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global S1P Receptor Modulator Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global S1P Receptor Modulator Drugs Market Share by Region: 2021 VS 2028
Figure 15. Global S1P Receptor Modulator Drugs Market Share by Players in 2021
Figure 16. Global Top S1P Receptor Modulator Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S1P Receptor Modulator Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by S1P Receptor Modulator Drugs Revenue in 2021
Figure 18. North America S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America S1P Receptor Modulator Drugs Market Share by Country (2017-2028)
Figure 20. United States S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe S1P Receptor Modulator Drugs Market Share by Country (2017-2028)
Figure 24. Germany S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific S1P Receptor Modulator Drugs Market Share by Region (2017-2028)
Figure 32. China S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America S1P Receptor Modulator Drugs Market Share by Country (2017-2028)
Figure 40. Mexico S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa S1P Receptor Modulator Drugs Market Share by Country (2017-2028)
Figure 44. Turkey S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Novartis International AG Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022)
Figure 47. Bristol Myers Squibb Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022)
Figure 48. Pfizer Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022)
Figure 49. Sanofi SA Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022)
Figure 50. Merck & Co., Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022)
Figure 51. Biogen Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022)
Figure 52. Roche Holding AG Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock